Head-to-head · WeighScore
FuturHealth vs Medsol RX
By GLP-1 ScorecardUpdated
Score comparison
Medsol RX has the higher recorded score — 65.8/100 to 65.6/100, but only just.
Medsol RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. MedSol Rx combines personal coaching with monthly or prepaid GLP-1 care. Its injection packages publish clear billed totals, but dose applicability, pharmacy assignment and shipment-dependent refund rules need attention. FuturHealth is close behind and may still be the better fit — see the factor split below.
Before you choose
Before comparing the headline prices, the FuturHealth review and the Medsol RX review set out what each semaglutide figure in the table below covers, including whether the medication is a brand-name product billed by a pharmacy. Brand-name and compounded prices are different products, so set like against like before treating either one as cheaper.
If neither one fits, FuturHealth vs Semaglutide Online and GOAL.MD vs Medsol RX compare each of them with another graded program, and the list of alternatives to FuturHealth ranks the programs closest to FuturHealth on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the PlexusDx review covers one graded close to these two, at 67.7/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | FuturHealth | Medsol RX |
|---|---|---|
| WeighScore | 65.6/100 | 65.8/100 |
| Grade | C | C |
| Site position | #235 | #228 |
| Semaglutide | $198/mo (Wegovy pill intro dose) | $169 first month, then $199/mo; six-month plan $894 billed total |
| Tirzepatide | $395/mo (Zepbound KwikPen intro dose) | $239 first month, then $259/mo; six-month plan $1,254 billed total |
| Coverage | Coverage not published | Nationwide delivery claimed; state/treatment eligibility unverified |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
Strengths
- Names the brand and format on its introductory price cards.
- Publishes its subscription cancellation and refund terms.
What to consider
- Introductory figures leave continuing and all-in charges open.
- The membership guarantee excludes medication and most third-party charges.
Site position #228 · C
Strengths
- Dedicated personal coaching described as included in every plan
- Posted injection schedules distinguish first month, ongoing monthly and prepaid totals
- Prescribing pathway names Open Loop clinicians after consultation
What to consider
- Dose-specific charges, post-term renewal and assigned dispensing pharmacy need confirmation
- Cancellation requires 72-hour notice; monthly current/prior charges generally not refunded
- Prepaid refunds cover months with no medication shipped; shipment schedule matters
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.